Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
51
DOCU Quote, Financials, Valuation and Earnings
Last price:
$77.65
Seasonality move
:
-1.9%
Day range:
$75.40 - $77.41
52-week range:
$48.80 - $107.86
Dividend yield:
0%
P/E ratio:
14.58x
P/S ratio:
5.36x
P/B ratio:
7.74x
Volume:
2.1M
Avg. volume:
4.1M
1-year change:
35.57%
Market cap:
$15.6B
Revenue:
$3B
EPS (TTM):
$5.29
Earnings Data
Next earnings date for DOCU
Sep 05
2025
Most recent earnings per share
$0.34
Missed by $0.47
(Jun 5/2025)
Consensus Estimate
$0.81
(Jun 5/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DOCU Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/05/2025 | Q3 | $780.4M | -- | -- | $0.85 | -- |
| 06/05/2025 | Q2 | $748.9M | $763.7M | $0.34 | $0.81 | -$0.47 |
| 03/13/2025 | Q1 | $761.6M | $776.3M | $0.39 | $0.85 | -$0.46 |
| 12/05/2024 | Q4 | $745.3M | $754.8M | $0.30 | $0.87 | -$0.57 |
| 09/05/2024 | Q3 | $727.8M | $736M | $4.26 | $0.81 | $3.45 |
| 06/06/2024 | Q2 | $707.4M | $709.6M | $0.16 | $0.79 | -$0.63 |
| 03/07/2024 | Q1 | $699.4M | $712.4M | $0.13 | $0.65 | -$0.52 |
| 12/07/2023 | Q4 | -- | -- | $0.19 | $0.63 | -$0.44 |
| 09/07/2023 | Q3 | -- | -- | $0.04 | $0.66 | -$0.62 |
| 06/08/2023 | Q2 | -- | -- | $0.00 | $0.56 | -$0.56 |
| 03/09/2023 | Q1 | -- | -- | $0.02 | $0.52 | -$0.50 |
| 12/08/2022 | Q4 | -- | -- | -$0.15 | $0.42 | -$0.57 |
| 09/08/2022 | Q3 | -- | -- | -$0.22 | $0.42 | -$0.64 |
| 06/09/2022 | Q2 | -- | -- | -$0.14 | $0.46 | -$0.60 |
| 03/10/2022 | Q1 | -- | -- | -$0.15 | $0.48 | -$0.63 |
| 12/02/2021 | Q4 | -- | -- | -$0.03 | $0.46 | -$0.49 |
| 09/02/2021 | Q3 | -- | -- | -$0.13 | $0.40 | -$0.53 |
| 06/03/2021 | Q2 | -- | -- | -$0.04 | $0.28 | -$0.32 |
| 03/11/2021 | Q1 | -- | -- | -$0.38 | $0.22 | -$0.60 |
| 12/03/2020 | Q4 | -- | -- | -$0.31 | $0.13 | -$0.44 |
| 09/03/2020 | Q3 | -- | -- | -$0.35 | $0.08 | -$0.43 |
| 06/04/2020 | Q2 | -- | -- | -$0.26 | $0.10 | -$0.36 |
| 03/12/2020 | Q1 | -- | -- | -$0.26 | $0.05 | -$0.31 |
| 12/05/2019 | Q4 | -- | -- | -$0.26 | $0.04 | -$0.30 |
| 09/05/2019 | Q3 | -- | -- | $0.01 | $0.04 | -$0.03 |
| 06/06/2019 | Q2 | -- | -- | $0.07 | $0.05 | $0.02 |
| 03/14/2019 | Q1 | -- | -- | $0.06 | $0.01 | $0.05 |
| 12/06/2018 | Q4 | -- | -- | -- | -$0.02 | -- |
| 09/05/2018 | Q3 | -- | -- | $0.03 | $0.01 | $0.02 |
| 06/07/2018 | Q2 | -- | -- | $0.01 | -$0.07 | $0.08 |
Docusign Earnings Questions
-
How Much did Docusign Generate in Revenue Last Quarter?
Docusign reported $763.7M worth of top line sales in its most recent quarter.
-
Did Docusign Beat Earnings Last Quarter?
Docusign announced earnings per share of $0.34 which represents a miss of analyst forecast a $0.81 per share.
-
Is Docusign Profitable?
Docusign reported $606.4M that represents $2.85 per share over the last quarter.
-
What is the Analyst Consensus for Docusign EPS Next Year?
Docusign's earnings are forecast to decrease from $5.08 per share to $3.54 per share next year representing a decrease of -29.69%.
-
When is Docusign's Earnings Date?
Docusign's next earnings date is September 5, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
